European Stock Index Fund - Institutional Plus EUR Acc (VANEIEP)
Related Documents
NAV Price ()
—
Number of stocks
—
—
Risk Indicator
—
Start a savings plan or make a one-off investment
Invest now with an online broker
Learn moreAbout this fund
Fund objectives
- The Fund employs a passive management – or indexing – investment approach and seeks to provide long-term capital growth by tracking the performance of the MSCI Europe Index (the “Index”).
- The Index is comprised of large and mid-sized company stocks in developed markets in Europe.
- The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.
Fund facts
Share class inception
06 Dec 2013
Minimum initial investment
€100,000,000.00
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Strategy
Index
Asset Class
Equity
Domicile
Ireland
Dividend schedule
—
Legal entity
Vanguard Investment Series PLC
Tax status
Austria, Germany, Switzerland and United Kingdom reporting
Benchmark
MSCI Europe Index
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at 31 Jan 2026
Beta
R²
Annualized Tracking Error
1 year
3 years
5 years
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 414 | 403 | 31 Jan 2026 |
| Median market capital | 82.9 B | 82.9 B | 31 Jan 2026 |
| 17.6 x | 17.6 x | 31 Jan 2026 | |
| 2.4 x | 2.5 x | 31 Jan 2026 | |
| 13.8% | 13.8% | 31 Jan 2026 | |
| 14.4% | 14.4% | 31 Jan 2026 | |
| Portfolio turnover rate | -40.0% | — | 31 Dec 2025 |
Market allocation
As at 31 Jan 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 20.57% | 22.51% | -1.94% |
| France | Europe | 14.70% | 15.56% | -0.86% |
| Germany | Europe | 14.23% | 14.23% | 0.00% |
| Switzerland | Europe | 14.22% | 14.22% | 0.00% |
| Netherlands | Europe | 9.72% | 8.22% | 1.50% |
| Sweden | Europe | 6.09% | 5.66% | 0.43% |
| Spain | Europe | 5.93% | 5.94% | -0.01% |
| Italy | Europe | 4.87% | 4.87% | 0.00% |
| Denmark | Europe | 3.00% | 3.01% | -0.01% |
| Belgium | Europe | 1.71% | 1.71% | 0.00% |
| Finland | Europe | 1.30% | 1.72% | -0.42% |
| Norway | Europe | 0.91% | 0.91% | 0.00% |
| Other | Other | 0.86% | 0.00% | 0.86% |
| Ireland | Europe | 0.70% | 0.70% | 0.00% |
| Austria | Europe | 0.43% | 0.43% | 0.00% |
Holdings details
As at 31 Jan 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 3.81479% | Information Technology | NL | €300,146,049.21 | 207,550 |
| Roche Holding AG | 2.17318% | Health Care | CH | €170,984,751.64 | 375,440 |
| HSBC Holdings PLC | 2.06369% | Financials | GB | €162,370,369.17 | 9,205,243 |
| AstraZeneca PLC | 1.96706% | Health Care | GB | €154,767,443.66 | 829,292 |
| Novartis AG | 1.92330% | Health Care | CH | €151,324,299.46 | 1,016,640 |
| Nestle SA | 1.66999% | Consumer Staples | CH | €131,394,452.89 | 1,377,915 |
| Siemens AG | 1.57497% | Industrials | DE | €123,918,286.51 | 406,413 |
| Shell PLC | 1.50979% | Energy | GB | €118,789,306.46 | 3,098,259 |
| SAP SE | 1.43987% | Information Technology | DE | €113,288,695.34 | 558,329 |
| Banco Santander SA | 1.29682% | Financials | ES | €102,033,101.73 | 7,956,153 |
Prices and distribution
Prices
NAV Price (EUR)
€271.56
Change
+€1.320.49% At closure 17 Feb 2026
NAV 52-week high
€271.56
At closure 18 Feb 2026
NAV 52-week low
€201.67
At closure 18 Feb 2026
NAV 52-week difference
€69.89
Change
+25.74% At closure 18 Feb 2026
Historical Prices
-
Inception date
06 Dec 2013
| Date | NAV (EUR) |
|---|---|
| 17 Feb 2026 | €271.5589 |
| 16 Feb 2026 | €270.2339 |
| 13 Feb 2026 | €269.7624 |
| 12 Feb 2026 | €269.9581 |
| 11 Feb 2026 | €271.3616 |
| 10 Feb 2026 | €271.4998 |
| 09 Feb 2026 | €271.5416 |
| 06 Feb 2026 | €269.7135 |
| 05 Feb 2026 | €266.7091 |
| 04 Feb 2026 | €269.5832 |
Distribution history
Distribution frequency
—
Historical performance 31 Jan 2026
2.77%
All dividends are reinvested for the "Accumulation" shares.
Purchase information
Currency
Base currency: EUR
Fund codes
- Bloomberg: VANEIEP
- Citi: JWGE
- ISIN: IE00BFPM9L96
- MEX ID: VIAABD
- SEDOL: BFPM9L9